Literature DB >> 9789052

Interleukin 12 deficiency associated with recurrent infections.

S Haraguchi1, N K Day, R P Nelson, P Emmanuel, J E Duplantier, C S Christodoulou, R A Good.   

Abstract

A 3-yr-old female patient exhibited interleukin 12 (IL-12) deficiency that was associated with recurrent episodes of pneumococcal pneumonia with sepsis and other infections in the absence of fevers. The patient's peripheral blood mononuclear cells (PBMCs) exhibited normal proliferative responses to antigens. Immune responses, including in vivo production of antibodies to diphtheria, tetanus, or pneumococcal antigens, were normal. Ig levels and B cell and T cell phenotypes were also normal. In contrast, IL-12 p70 heterodimer production was undetectable by using supernatants of the patient's stimulated PBMCs when compared with control cells treated similarly. Although present, interferon gamma (IFN-gamma) was reduced. The addition of recombinant IFN-gamma to control cells enhanced the production of IL-12 by up to sixfold. By contrast, IL-12 was undetectable in supernatants of the patient's cells in the presence of recombinant IFN-gamma. IL-12 p40 subunit mRNA by using the patient's PBMCs after stimulation with Staphylococcus aureus Cowan strain 1 or lipopolysaccharide was also undetectable by reverse transcription-PCR when compared with control cells. Production of IL-2, IL-6, tumor necrosis factor alpha, or IFN-gamma of the patient's PBMCs after appropriate stimulation was observed. This patient has either a defect in Staphylococcus aureus Cowan strain 1-lipopolysaccharide- or staphylococcal enterotoxin A-induced signaling pathways for the activation of IL-12 p40 gene expression, or an abnormality in the IL-12 p40 gene itself.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789052      PMCID: PMC23732          DOI: 10.1073/pnas.95.22.13125

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.

Authors:  J Magram; S E Connaughton; R R Warrier; D M Carvajal; C Y Wu; J Ferrante; C Stewart; U Sarmiento; D A Faherty; M K Gately
Journal:  Immunity       Date:  1996-05       Impact factor: 31.745

Review 2.  IL-12: a key cytokine in immune regulation.

Authors:  A G Lamont; L Adorini
Journal:  Immunol Today       Date:  1996-05

Review 3.  Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome.

Authors:  C A Biron; R T Gazzinelli
Journal:  Curr Opin Immunol       Date:  1995-08       Impact factor: 7.486

4.  IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.

Authors:  J R Piccotti; S Y Chan; R E Goodman; J Magram; E J Eichwald; D K Bishop
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

5.  Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

Authors:  M Wysocka; M Kubin; L Q Vieira; L Ozmen; G Garotta; P Scott; G Trinchieri
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

6.  Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation.

Authors:  D M Frucht; S M Holland
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

7.  Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes.

Authors:  M P Hayes; J Wang; M A Norcross
Journal:  Blood       Date:  1995-07-15       Impact factor: 22.113

8.  Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells.

Authors:  M Kubin; J M Chow; G Trinchieri
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

Review 9.  Interleukin-12.

Authors:  M J Brunda
Journal:  J Leukoc Biol       Date:  1994-02       Impact factor: 4.962

10.  Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha.

Authors:  I E Flesch; J H Hess; S Huang; M Aguet; J Rothe; H Bluethmann; S H Kaufmann
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

View more
  26 in total

1.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

3.  Inhibition of p38 MAP kinase during cellular activation results in IFN-gamma-dependent augmentation of IL-12 production by human monocytes/macrophages.

Authors:  J B Marriott; I A Clarke; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

4.  STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.

Authors:  C J Godshall; A B Lentsch; J C Peyton; M J Scott; W G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 5.  Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway.

Authors:  D A Lammas; J L Casanova; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

6.  The Nature of Antibacterial Adaptive Immune Responses against Staphylococcus aureus Is Dependent on the Growth Phase and Extracellular Peptidoglycan.

Authors:  Payal P Balraadjsing; Lisbeth D Lund; Yuri Souwer; Sebastian A J Zaat; Hanne Frøkiær; Esther C de Jong
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

7.  Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection.

Authors:  K K Tekkanat; H Maassab; A A Berlin; P M Lincoln; H L Evanoff; M H Kaplan; N W Lukacs
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 8.  Inherited human IRAK-4 deficiency: an update.

Authors:  Capucine Picard; Horst von Bernuth; Cheng-Lung Ku; Kun Yang; Anne Puel; Jean-Laurent Casanova
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 9.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.

Authors:  David A Lammas; E De Heer; J D Edgar; V Novelli; A Ben-Smith; R Baretto; P Drysdale; J Binch; C MacLennan; D S Kumararatne; S Panchalingam; T H M Ottenhoff; J-L Casanova; J F Emile
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

10.  Open and laparoscopic spleen-preserving, splenic vessel-preserving distal pancreatectomy: indications and outcomes.

Authors:  Matias Bruzoni; Aaron R Sasson
Journal:  J Gastrointest Surg       Date:  2008-04-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.